Prescription drug · ANDA
Terazosin (Terazosin hydrochloride) NDC 70518-0074
Terazosin hydrochloride 2 mg/1 · Capsule · Oral · REMEDYREPACK INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70518-0074-1 | 7051800740170518007401 | 30 CAPSULE in 1 BLISTER PACK (70518-0074-1)Marketed from Mar 24, 2021 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Terazosin
- Generic name (nonproprietary)
- terazosin hydrochloride
- Active ingredients
- Terazosin hydrochloride — 2 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- REMEDYREPACK INC.NDC labeler code 70518
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 075317
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Antagonists (Mechanism)
- Identifiers
- Product ID 70518-0074_522c0862-82ce-90ce-e063-6394a90a48b5SPL ID 522c0862-82ce-90ce-e063-6394a90a48b5SPL set ID a3a5901a-6395-4030-a27b-1fb17cd97315RxCUI 313217UNII D32S14F082
- Pharmacologic class
- alpha-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470518007401followed by a unit qualifier and the quantityPackage 70518-0074-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). There is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of BPH when treated with terazosin capsules. The long-term effects of terazosin capsules on the incidence of surgery, acute urinary obstruction or other complications of BPH are yet to be determined. Terazosin capsules are also indicated for the treatment of hypertension. Terazosin capsules can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.
Excerpt only. Read the full label for complete information.
About NDC 70518-0074
- What is NDC 70518-0074?
- 70518-0074 is the product NDC for Terazosin (terazosin hydrochloride), Terazosin hydrochloride 2 mg/1 capsule, listed with the FDA by REMEDYREPACK INC.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Terazosin (Terazosin Hydrochloride).
- What is the active ingredient?
- Terazosin hydrochloride.
- Who is the labeler?
- REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Terazosin?
- 61 other product NDCs are listed under this name. See all Terazosin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Terazosin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Terazosin | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | 68788-4064 | 68788-4064-0168788-4064-03 |
| Terazosin | Terazosin hydrochloride 2 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-4545 | 70518-4545-00 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Coupler LLC | 67046-1622 | 67046-1622-03 |
| Terazosin | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Ajanta Pharma USA Inc. | 27241-288 | 27241-0288-0127241-0288-10 |
| Terazosin | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Ajanta Pharma USA Inc. | 27241-289 | 27241-0289-0127241-0289-10 |
| Terazosin | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Ajanta Pharma USA Inc. | 27241-290 | 27241-0290-0127241-0290-10 |
| Terazosin | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Ajanta Pharma USA Inc. | 27241-291 | 27241-0291-0127241-0291-10 |
| Terazosin | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Bionpharma Inc. | 69452-330 | 69452-0330-2069452-0330-32 |
| Terazosin | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Bionpharma Inc. | 69452-331 | 69452-0331-2069452-0331-32 |
| Terazosin | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Bionpharma Inc. | 69452-332 | 69452-0332-2069452-0332-32 |
Other NDCs under ANDA 075317
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | AvKARE | 42291-820 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | AvKARE | 42291-821 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | AvKARE | 42291-822 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | AvKARE | 42291-823 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-0657 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-1559 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-2371 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-2623 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | AvPAK | 50268-764 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | AvPAK | 50268-765 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | AvPAK | 50268-766 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | AvPAK | 50268-767 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Jubilant Cadista Pharmaceuticals Inc. | 59746-383 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Jubilant Cadista Pharmaceuticals Inc. | 59746-384 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Jubilant Cadista Pharmaceuticals Inc. | 59746-385 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Jubilant Cadista Pharmaceuticals Inc. | 59746-386 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Proficient Rx LP | 63187-456 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Proficient Rx LP | 63187-620 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Bryant Ranch Prepack | 63629-2439 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Bryant Ranch Prepack | 63629-5237 |
Showing 20 of 39.